M. Wolf

发表

FGF23 Modifies the Relationship Between Vitamin D and Cardiac Remodeling

M. Wolf, M. Keane, J. Shults, 2013, Circulation. Heart failure.

Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes.

S. Bandinelli, L. Ferrucci, B. Kestenbaum, 2012, JAMA.

Vitamin D deficiency, inflammation, and albuminuria in chronic kidney disease: complex interactions.

M. Wolf, A. Levin, O. Gutiérrez, 2011, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Chronic kidney disease, hypovitaminosis D, and mortality in the United States.

Keith C. Norris, M. Wolf, S. Adler, 2009, Kidney international.

Vitamin D Deficiency and Risk of Cardiovascular Disease

Michael J. Pencina, Ralph B. D'Agostino, Erik Ingelsson, 2008, Circulation.

Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy.

M. Wolf, E. Lowrie, R. Thadhani, 2003, The New England journal of medicine.

Common genetic determinants of vitamin D insufficiency: a genome-wide association study

Daniel L. Koller, P. O’Reilly, D. Kiel, 2010, The Lancet.

Kidney Functional Magnetic Resonance Imaging and Change in eGFR in Individuals with CKD.

A. Cheung, M. Wolf, A. Srivastava, 2020, Clinical journal of the American Society of Nephrology : CJASN.

Multicenter Study Evaluating Intrarenal Oxygenation and Fibrosis Using Magnetic Resonance Imaging in Individuals With Advanced CKD

A. Cheung, M. Wolf, L. Fried, 2018, Kidney international reports.

Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD.

O. Gutiérrez, T. Isakova, L. Castaldo, 2008, Journal of the American Society of Nephrology : JASN.

FGF23 and klotho at the intersection of kidney and cardiovascular disease

M. Wolf, Daniel L. Edmonston, A. Grabner, 2023, Nature reviews. Cardiology.

FGFR4 does not contribute to progression of chronic kidney disease

M. Wolf, C. Faul, Tomokazu Souma, 2019, Scientific Reports.

FGF23 and Nutritional Metabolism.

M. Wolf, L. Pool, Lindsay R. Pool, 2017, Annual review of nutrition.

Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease.

M. Wolf, M. Czaja, R. Bartz, 2016, Kidney international.

Fibroblast Growth Factor 23 and Cause-Specific Mortality in the General Population: The Northern Manhattan Study.

R. Sacco, M. Wolf, M. Elkind, 2016, The Journal of clinical endocrinology and metabolism.

Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy.

A. Ullrich, M. Wolf, J. Stypmann, 2015, Cell metabolism.

Hunt for the culprit of cardiovascular injury in kidney disease.

C. Faul, M. Wolf, 2015, Cardiovascular Research.

Mineral (Mal)Adaptation to Kidney Disease--Young Investigator Award Address: American Society of Nephrology Kidney Week 2014.

M. Wolf, M. Wolf, 2015, Clinical journal of the American Society of Nephrology : CJASN.

In search of the fountain of youth.

M. Wolf, M. Wolf, 2014, Journal of the American Society of Nephrology : JASN.

Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease

M. Wolf, J. Scialla, M. Wolf, 2014, Nature Reviews Nephrology.

Phosphate Metabolism and Fibroblast Growth Factor 23 in Chronic Kidney Disease

M. Wolf, T. Isakova, Jessica L. Houston, 2013 .

αKlotho: FGF23 coreceptor and FGF23-regulating hormone.

M. Wolf, H. Jüppner, M. Wolf, 2012, The Journal of clinical investigation.

Expression of fgf23 and αklotho in developing embryonic tissues and adult kidney of the zebrafish, Danio rerio.

M. Wolf, H. Jüppner, C. Faul, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Partial answers from partial Klotho deficiency.

M. Wolf, T. Isakova, M. Wolf, 2012, Journal of the American Society of Nephrology : JASN.

FGF-23 levels in patients with AKI and risk of adverse outcomes.

Herbert Chase, Sushrut S Waikar, Myles Wolf, 2012, Clinical journal of the American Society of Nephrology : CJASN.

UPDATE ON FIBROBLAST GROWTH FACTOR 23 IN CHRONIC KIDNEY DISEASE

M. Wolf, M. Wolf, 2012, Kidney international.

FGF23 induces left ventricular hypertrophy.

A. Go, M. Wolf, M. Keane, 2011, The Journal of clinical investigation.

Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease.

Jiang He, Harold I Feldman, Huiliang Xie, 2011, JAMA.

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.

Huiliang Xie, M. Wolf, R. Townsend, 2011, Kidney international.

Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality.

M. Wolf, C. Kovesdy, M. Molnar, 2011, Journal of the American Society of Nephrology : JASN.

Tertiary excess of fibroblast growth factor 23 and hypophosphatemia following kidney transplantation

M. Wolf, W. Seeherunvong, M. Wolf, 2011, Pediatric transplantation.

Forging forward with 10 burning questions on FGF23 in kidney disease.

M. Wolf, M. Wolf, 2010, Journal of the American Society of Nephrology : JASN.

Recent advances in the rapidly evolving field of fibroblast growth factor 23 in chronic kidney disease

M. Wolf, Anna L Zisman, A. Zisman, 2010, Current opinion in nephrology and hypertension.

FGF-23: More Than a Regulator of Renal Phosphate Handling?

M. Wolf, H. Jüppner, I. Salusky, 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Elevated FGF-23 in a patient with rhabdomyolysis-induced acute kidney injury.

D. Leaf, M. Wolf, L. Stern, 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active.

M. Wolf, H. Jüppner, T. Shimada, 2010, The Journal of clinical endocrinology and metabolism.

Fibroblast growth factor 23 and the future of phosphorus management

M. Wolf, M. Wolf, 2009, Current opinion in nephrology and hypertension.

Klotho Variants and Chronic Hemodialysis Mortality

M. Wolf, M. Tonelli, C. Zoccali, 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease.

M. Wolf, O. Gutiérrez, T. Isakova, 2009, Kidney international.

Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease see commentary on page 928

M. Wolf, M. Czaja, R. Bartz, 2016 .

Expression of fgf 23 and α klotho in developing embryonic tissues and adult kidney of the zebra fi sh , Danio rerio

M. Wolf, H. Jüppner, C. Faul, 2012 .

Exceptional Cases Elevated FGF-23 in a patient with rhabdomyolysis-induced acute kidney injury

D. Leaf, M. Wolf, L. Stern, 2010 .

Abnormalities in Cardiac Structure and Function among Individuals with CKD: The COMBINE Trial

M. Wolf, L. Fried, M. Chonchol, 2021, Kidney360.

Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance.

M. Wolf, R. Ness, V. Sukhatme, 2004, The Journal of clinical endocrinology and metabolism.

Klotho, an antiaging molecule, attenuates oxidant-induced alveolar epithelial cell mtDNA damage and apoptosis.

M. Wolf, Dong-Hyun Kim, M. Eren, 2017, American journal of physiology. Lung cellular and molecular physiology.

Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study

A. Go, Mahboob Rahman, M. Wolf, 2019, Journal of the American Heart Association.

Klotho , an anti-aging molecule , attenuates oxidant-induced alveolar epithelial 1 cell mtDNA damage and apoptosis 2 3

Douglas, M. Wolf, Dong-Hyun Kim, 2017 .

Impact of westernization on fibroblast growth factor 23 levels among individuals of African ancestry.

M. Wolf, A. Luke, R. Cooper, 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Incidence and Progression of Chronic Kidney Disease in Black and White Individuals with Type 2 Diabetes.

M. Wolf, M. Carnethon, T. Craven, 2018, Clinical journal of the American Society of Nephrology : CJASN.

Genetic African Ancestry and Markers of Mineral Metabolism in CKD.

M. Wolf, H. Feldman, J. Chen, 2016, Clinical journal of the American Society of Nephrology : CJASN.

Common genetic determinants of vitamin D insufficiency

Daniel L. Koller, P. O’Reilly, D. Kiel, 2011 .

N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations in hemodialysis patients: prognostic value of baseline and follow-up measurements.

M. Wolf, M. Tonelli, I. Bhan, 2008, Clinical chemistry.

Mechanism of action of SNF472, a novel calcification inhibitor to treat vascular calcification and calciphylaxis

M. Wolf, Nadine Kaesler, A. Gold, 2020, British journal of pharmacology.

Associations of FGF23 with 10-Year Change in eGFR and UACR and with Incident CKD in the CARDIA Cohort

C. Yancy, M. Carnethon, O. Gutiérrez, 2023, Kidney360.

Fibroblast growth factor-23 and cardiovascular events in CKD.

A. Go, Mahboob Rahman, Huiliang Xie, 2014, Journal of the American Society of Nephrology : JASN.

Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease

Thomas J. Wang, U. Hoffmann, R. Christenson, 2009, Circulation.

First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction.

M. Wolf, H. Cuckle, H. Meiri, 2007, American journal of obstetrics and gynecology.

Insulin Resistance and Alterations in Angiogenesis: Additive Insults That May Lead to Preeclampsia

M. Wolf, V. Sukhatme, R. Levine, 2004, Hypertension.

Mineral bone disease in autosomal dominant polycystic kidney disease.

Lorien S. Dalrymple, M. Wolf, A. Chapman, 2020, Kidney international.

Interactions between FGF23 and Genotype in Autosomal Dominant Polycystic Kidney Disease.

M. Wolf, A. Chapman, M. Chonchol, 2020, Kidney360.

Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease.

Kaleab Z. Abebe, M. Wolf, A. Chapman, 2017, Clinical journal of the American Society of Nephrology : CJASN.

Inflammatory Markers and Incidence of Hospitalization with Infection in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study.

M. Wolf, L. Appel, H. Feldman, 2020, American journal of epidemiology.

Plasma gelsolin and circulating actin correlate with hemodialysis mortality.

I. Bhan, Yuchiao Chang, R. Thadhani, 2009, Journal of the American Society of Nephrology : JASN.

Impact of activated vitamin D and race on survival among hemodialysis patients.

N. Powe, M. Wolf, M. Stampfer, 2008, Journal of the American Society of Nephrology : JASN.

Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.

M. Wolf, H. Jüppner, E. Rhee, 2005, Journal of the American Society of Nephrology : JASN.

Activated injectable vitamin D and hemodialysis survival: a historical cohort study.

M. Hernán, M. Wolf, C. Camargo, 2005, Journal of the American Society of Nephrology : JASN.

Association between Patient Race and Staff Resuscitation Efforts After Cardiac Arrest in Outpatient Dialysis Clinics: a study from the CARES Surveillance Group.

B. McNally, M. Wolf, L. Svetkey, 2020, Resuscitation.

Atrial Fibrillation and Risk of ESRD in Adults with CKD.

A. Go, M. Keane, E. Soliman, 2016, Clinical journal of the American Society of Nephrology : CJASN.

Interpreting cardiac troponin results from high-sensitivity assays in chronic kidney disease without acute coronary syndrome.

M. Wolf, S. Seliger, R. Christenson, 2012, Clinical chemistry.

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.

M. Wolf, Hang Lee, H. Jüppner, 2008, The New England journal of medicine.

Correlates of left ventricular mass in chronic hemodialysis recipients

M. Wolf, Z. Harel, J. Perl, 2013, The International Journal of Cardiovascular Imaging.

Genetic Variants Associated with Circulating Fibroblast Growth Factor 23.

B. Kestenbaum, C. Robinson-Cohen, I. D. de Boer, 2018, Journal of the American Society of Nephrology : JASN.

Fibroblast Growth Factor 23 Levels Associate with AKI and Death in Critical Illness.

D. Leaf, M. Wolf, K. Jacob, 2017, Journal of the American Society of Nephrology : JASN.

Kidney to bone via bedside to bench…and back?

M. Wolf, A. Grabner, M. Wolf, 2020, The Journal of clinical investigation.

Regulation and Effects of FGF23 in Chronic Kidney Disease.

M. Wolf, J. Musgrove, M. Wolf, 2019, Annual review of physiology.

Fibroblast Growth Factor 23 Associates with Death in Critically Ill Patients.

D. Leaf, M. Wolf, A. Ginde, 2018, Clinical journal of the American Society of Nephrology : CJASN.

Fibroblast growth factor 23 levels are elevated and associated with severe acute kidney injury and death following cardiac surgery.

D. Leaf, M. Wolf, S. Waikar, 2016, Kidney International.

Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease

M. Wolf, K. White, M. Wolf, 2014, Current opinion in nephrology and hypertension.

Dysregulated mineral metabolism in patients with acute kidney injury and risk of adverse outcomes

D. Leaf, M. Wolf, S. Cremers, 2013, Clinical endocrinology.

Plasma FGF23 levels increase rapidly after acute kidney injury

D. Leaf, M. Wolf, S. Waikar, 2013, Kidney international.

Earlier Onset and Greater Severity of Disordered Mineral Metabolism in Diabetic Patients With Chronic Kidney Disease

Huiliang Xie, M. Wolf, H. Feldman, 2012, Diabetes Care.

Tubular markers are associated with decline in kidney function in proteinuric type 2 diabetic patients.

H. Parving, M. Wolf, P. Rossing, 2012, Diabetes Research and Clinical Practice.

Fibroblast Growth Factor 23 and Risk of Hospitalization with Infection in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study.

M. Wolf, L. Appel, A. Srivastava, 2020, Journal of the American Society of Nephrology : JASN.

Biomarkers of Mineral and Bone Metabolism and 20-Year Risk of Hospitalization With Infection: The Atherosclerosis Risk in Communities Study

J. Coresh, M. Wolf, K. Matsushita, 2017, The Journal of clinical endocrinology and metabolism.

Calciphylaxis from nonuremic causes: a systematic review.

J. Hix, R. Sterns, Sagar U. Nigwekar, 2008, Clinical journal of the American Society of Nephrology : CJASN.

Patients with Fabry disease on dialysis in the United States.

M. Wolf, M. Tonelli, R. Thadhani, 2002, Kidney international.

A Pilot Randomized Trial of Ferric Citrate Coordination Complex for the Treatment of Advanced CKD.

M. Wolf, G. Chertow, G. Block, 2019, Journal of the American Society of Nephrology : JASN.

Effects of phosphate binders in moderate CKD.

B. Kestenbaum, M. Wolf, D. Wheeler, 2012, Journal of the American Society of Nephrology : JASN.

Ferric citrate reduces fibroblast growth factor 23 levels and improves renal and cardiac function in a mouse model of chronic kidney disease.

M. Wolf, Claire Gerber, V. David, 2019, Kidney international.

FGF23 at the crossroads of phosphate, iron economy and erythropoiesis

M. Wolf, Daniel L. Edmonston, M. Wolf, 2019, Nature Reviews Nephrology.

Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production

M. Wolf, Herbert Y. Lin, Jodie L Babitt, 2015, Kidney international.

Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women

M. Wolf, D. Bregman, Todd A. Koch, 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Phosphorus binders and survival on hemodialysis.

M. Wolf, Yuchiao Chang, R. Thadhani, 2009, Journal of the American Society of Nephrology : JASN.

Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD.

M. Pencina, A. Go, M. Wolf, 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

First-trimester C-reactive protein and subsequent gestational diabetes.

M. Wolf, R. Thadhani, J. Ecker, 2003, Diabetes care.

Serum Calcification Propensity and Coronary Artery Calcification Among Patients With CKD: The CRIC (Chronic Renal Insufficiency Cohort) Study.

A. Go, I. D. de Boer, M. Wolf, 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Serum levels of fibroblast growth factor 23 are elevated in patients with active Lupus nephritis

M. Wolf, V. Jorgetti, R. Elias, 2017, Cytokine.

Food Access, Chronic Kidney Disease, and Hypertension in the U.S.

M. Wolf, C. Anderson, L. Boulware, 2015, American journal of preventive medicine.

Vasopressin release is enhanced by the Hemocontrol biofeedback system and could contribute to better haemodynamic stability during haemodialysis

M. Wolf, D. Goldsmith, S. Marx, 2013 .

Hepatic and renal improvements with FXR agonist vonafexor in individuals with suspected fibrotic NASH.

M. Wolf, A. Sanyal, C. Bureau, 2022, Journal of hepatology.

Statistical Methods for Cohort Studies of CKD: Survival Analysis in the Setting of Competing Risks.

Mahboob Rahman, M. Wolf, J. Roy, 2017, Clinical journal of the American Society of Nephrology : CJASN.

Race, Genetic Ancestry, and Estimating Kidney Function in CKD.

A. Go, M. Wolf, S. Waikar, 2021, The New England journal of medicine.

First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia.

Robert N. Taylor, M. Wolf, V. Sukhatme, 2004, The Journal of clinical endocrinology and metabolism.

A Patient With CKD Develops Cholestatic Liver Injury During a Clinical Trial

A. Cheung, M. Wolf, C. Martínez, 2017, Kidney international reports.

Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD.

A. Cheung, M. Wolf, J. Kusek, 2015, Journal of the American Society of Nephrology : JASN.

Fibroblast growth factor 23 and Inflammation in CKD.

Huiliang Xie, M. Kretzler, S. Navaneethan, 2012, Clinical journal of the American Society of Nephrology : CJASN.

Fibroblast growth factor 23 is not associated with and does not induce arterial calcification

M. Budoff, Mahboob Rahman, M. Reilly, 2013, Kidney international.

Targeting Vascular Calcification in Chronic Kidney Disease

M. Wolf, P. Raggi, G. Chertow, 2020, JACC. Basic to translational science.

Fibroblast Growth Factor 23 Is Associated With Carotid Plaque Presence and Area: The Northern Manhattan Study

R. Sacco, M. Wolf, M. Elkind, 2015, Arteriosclerosis, thrombosis, and vascular biology.

A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5.

M. Wolf, G. Chertow, S. Fishbane, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study.

A. Go, G. Ying, M. Wolf, 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Phosphate homeostasis in CKD: report of a scientific symposium sponsored by the National Kidney Foundation.

M. Wolf, M. Tonelli, D. Wheeler, 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Fibroblast Growth Factor 23 Induces Left Ventricular Hypertrophy

M. Kuro-o, J. Hare, O. Moe, 2012 .

Fibroblast growth factor 23, cardiovascular disease risk factors, and phosphorus intake in the health professionals follow-up study.

M. Wolf, E. Taylor, O. Gutiérrez, 2011, Clinical journal of the American Society of Nephrology : CJASN.

Correlates of osteoprotegerin and association with aortic pulse wave velocity in patients with chronic kidney disease.

M. Budoff, M. Wolf, L. Appel, 2011, Clinical journal of the American Society of Nephrology : CJASN.

Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC)

A. Go, M. Wolf, M. Keane, 2013, BMC Nephrology.

Fibroblast Growth Factor-23 and a Vegetarian Diet.

D. Prabhakaran, M. Wolf, Ruby Gupta, 2020, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

FGF23/FGFR4-mediated left ventricular hypertrophy is reversible

M. Wolf, J. Stypmann, M. Wacker, 2017, Scientific Reports.

Fibroblast Growth Factor-23 (FGF-23) Levels Differ Across Populations by Degree of Industrialization.

A. Luke, R. Cooper, T. Forrester, 2016, The Journal of clinical endocrinology and metabolism.

Klotho and phosphate are modulators of pathologic uremic cardiac remodeling.

Han Jun Cho, M. Wolf, Masaya Takahashi, 2015, Journal of the American Society of Nephrology : JASN.

Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD.

M. Wolf, J. Stypmann, H. Pavenstädt, 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Plasma FGF23 and the risk of stroke

R. Sacco, M. Wolf, M. Elkind, 2014, Neurology.

Dietary Phosphorus Restriction in Advanced Chronic Kidney Disease: Merits, Challenges, and Emerging Strategies

M. Wolf, O. Gutiérrez, M. Wolf, 2010, Seminars in dialysis.

Fibroblast Growth Factor-23 and Vegetarian Diet in India

M. Wolf, Ruby Gupta, S. Anand, 2020 .

Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD.

M. Wolf, S. Seliger, R. Christenson, 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

FGF23 in chronic kidney disease.

M. Wolf, P. Wahl, M. Wolf, 2012, Advances in experimental medicine and biology.

Vitamin D Therapy in Individuals With Prehypertension or Hypertension: The DAYLIGHT Trial

F. Harrell, M. Sabatine, J. Dusek, 2015, Circulation.

VITAMIN D IN HEALTH AND DISEASE: Beyond Minerals and Parathyroid Hormone: Role of Active Vitamin D in End‐Stage Renal Disease

M. Wolf, R. Thadhani, M. Wolf, 2005, Seminars in dialysis.

Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease

Anna C. Porter, M. Budoff, Mahboob Rahman, 2017, JAMA cardiology.

Racial/Ethnic Differences in Left Ventricular Structure and Function in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort

M. Budoff, A. Go, M. Wolf, 2017, American journal of hypertension.

Race/Ethnicity and Cardiovascular Outcomes in Adults With CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic CRIC Studies.

A. Go, Mahboob Rahman, M. Wolf, 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Racial differences in postprandial mineral ion handling in health and in chronic kidney disease.

M. Wolf, O. Gutiérrez, T. Isakova, 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Low socioeconomic status associates with higher serum phosphate irrespective of race.

M. Wolf, H. Feldman, J. Chen, 2010, Journal of the American Society of Nephrology : JASN.

Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.

Mahboob Rahman, T. Hostetter, M. Wolf, 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Mineral metabolites and CKD progression in African Americans.

Huiliang Xie, B. Astor, L. Appel, 2013, Journal of the American Society of Nephrology : JASN.

Genetic Variants Associated with Circulating Parathyroid Hormone.

Daniel L. Koller, J. Pankow, A. Paterson, 2017, Journal of the American Society of Nephrology : JASN.

Phosphate: a novel cardiovascular risk factor.

M. Wolf, E. Ritz, M. Ketteler, 2013, European heart journal.

Health Behaviors in Younger and Older Adults With CKD: Results From the CRIC Study

A. Go, Mahboob Rahman, M. Wolf, 2018, Kidney international reports.

Time-Updated Changes in Estimated GFR and Proteinuria and Major Adverse Cardiac Events: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.

A. Go, Mahboob Rahman, M. Wolf, 2021, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Association of Fitness With Racial Differences in Chronic Kidney Disease.

C. Lewis, M. Wolf, S. Sidney, 2019, American journal of preventive medicine.

Risk Factors for Heart Failure in Patients With Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study

A. Go, Mahboob Rahman, M. Wolf, 2017, Journal of the American Heart Association.

Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease.

M. Wolf, Jiang He, M. Kretzler, 2017, Kidney international.

Fibroblast Growth Factor 23 and Incident Cardiovascular Disease and Mortality in Middle‐Aged Adults

M. Wolf, M. Carnethon, H. Kramer, 2021, Journal of the American Heart Association.

Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression.

B. Astor, M. Wolf, L. Appel, 2015, Clinical journal of the American Society of Nephrology : CJASN.

Effects of etelcalcetide on fibroblast growth factor 23 in patients with secondary hyperparathyroidism receiving hemodialysis

M. Wolf, M. Vervloet, G. Chertow, 2019, Clinical kidney journal.

Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease.

M. Wolf, A. Levin, O. Gutiérrez, 2008, Kidney international.

INFLAMMATION AND GLUCOSE INTOLERANCE: A PROSPECTIVE STUDY OF GESTATIONAL DIABETES MELLITUS.

M. Wolf, R. Thadhani, J. Sauk, 2003, Journal of Investigative Medicine.

Leaky channels make weak muscles

M. Wolf, H. Jüppner, M. Wolf, 2022 .

The Association Between Conversion to In-centre Nocturnal Hemodialysis and Left Ventricular Mass Regression in Patients With End-Stage Renal Disease.

J. Leipsic, M. Wolf, Z. Harel, 2016, The Canadian journal of cardiology.

Change in Cardiac Biomarkers and Risk of Incident Heart Failure and Atrial Fibrillation in CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.

A. Go, M. Wolf, E. Soliman, 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Modifiers of Plasma 25-Hydroxyvitamin D and Chronic Kidney Disease Outcomes in Black Americans: The Jackson Heart Study.

M. Wolf, J. Pendergast, C. Diamantidis, 2019, The Journal of clinical endocrinology and metabolism.

Disordered FGF23 and mineral metabolism in children with CKD.

M. Wolf, S. Messinger, S. Furth, 2014, Clinical journal of the American Society of Nephrology : CJASN.

Fibroblast growth factor 23 in patients undergoing peritoneal dialysis.

Huiliang Xie, M. Wolf, T. Ikizler, 2011, Clinical journal of the American Society of Nephrology : CJASN.

Pruning the ricket thicket.

M. Wolf, V. David, M. Wolf, 2016, The Journal of clinical investigation.

Agonistic Angiotensin II Type 1 Receptor Autoantibodies in Postpartum Women With a History of Preeclampsia

M. Wolf, G. Wallukat, F. Luft, 2007, Hypertension.

Differential risk of hypertensive disorders of pregnancy among Hispanic women.

M. Wolf, R. Thadhani, J. Sauk, 2004, Journal of the American Society of Nephrology : JASN.

Predicting gestational diabetes: choosing the optimal early serum marker.

M. Wolf, R. Thadhani, J. Ecker, 2007, American journal of obstetrics and gynecology.

Early pregnancy insulin resistance and subsequent gestational diabetes mellitus.

M. Wolf, R. Thadhani, J. Ecker, 2005, Diabetes care.

First-trimester sex hormone binding globulin and subsequent gestational diabetes mellitus.

M. Wolf, D. Nathan, R. Thadhani, 2003, American journal of obstetrics and gynecology.

Obesity and Preeclampsia: The Potential Role of Inflammation

R. Thadhani, J. Ecker, J. Roberts, 2001, Obstetrics and gynecology.

Diuretics, calciuria and secondary hyperparathyroidism in the Chronic Renal Insufficiency Cohort.

M. Wolf, H. Feldman, R. Townsend, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Postpartum Diabetes Screening in Women With a History of Gestational Diabetes

M. Wolf, L. Chasan-Taber, R. Thadhani, 2005, Obstetrics and gynecology.

Designing, Conducting, Monitoring, and Analyzing Data from Pragmatic Randomized Clinical Trials: Proceedings from a Multi-stakeholder Think Tank Meeting

Lin Wang, Adrian F Hernandez, Jesse A Berlin, 2020, Therapeutic Innovation & Regulatory Science.

A Comparative Study of Serum Phosphate and Related Parameters in Chronic Kidney Disease between the USA and Japan

Anna C. Porter, M. Wolf, H. Feldman, 2022, American Journal of Nephrology.

Fibroblast growth factor 23 and incident CKD in type 2 diabetes.

Huiliang Xie, M. Wolf, T. Craven, 2015, Clinical journal of the American Society of Nephrology : CJASN.

Serum Phosphorus and Progression of CKD and Mortality: A Meta-analysis of Cohort Studies.

Luxia Zhang, Yan Zha, Jinwei Wang, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Higher net acid excretion is associated with a lower risk of kidney disease progression in patients with diabetes.

M. Wolf, L. Appel, H. Feldman, 2017, Kidney International.

Plant protein intake is associated with fibroblast growth factor 23 and serum bicarbonate levels in patients with chronic kidney disease: the Chronic Renal Insufficiency Cohort study.

Anna C. Porter, M. Wolf, L. Appel, 2012, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Plant Protein Intake Is Associated with Fibroblast Growth Factor 23 and Serum Bicarbonate in Patients with CKD: The Chronic Renal Insufficiency Cohort Study

Yang, Wei, Anna C. Porter, 2012 .

Vitamin D deficiency and anemia in early chronic kidney disease.

M. Wolf, A. Levin, O. Gutiérrez, 2010, Kidney international.

Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials.

M. Wolf, M. Econs, J. Rubin, 2020, JAMA.

Randomized trial of intravenous iron-induced hypophosphatemia.

I. Macdougall, G. Chertow, W. Strauss, 2018, JCI insight.

Fibroblast Growth Factor 23 Is Associated With Subclinical Cerebrovascular Damage: The Northern Manhattan Study

C. DeCarli, R. Sacco, M. Wolf, 2016, Stroke.

Chronic kidney disease in patients with cognitive impairment: a marker of microvascular damage or an independent risk factor?

M. Wolf, C. Wright, Jessica R. L. Warsch, 2010 .

Asymptomatic Ventricular Arrhythmia and Clinical Outcomes in Chronic Kidney Disease: A Pilot Study

M. Wolf, M. Wolf, R. Watanabe, 2016, Cardiorenal Medicine.

FGF23 and Left Ventricular Hypertrophy in Children with CKD.

M. Wolf, A. Betoko, S. Furth, 2018, Clinical journal of the American Society of Nephrology : CJASN.

Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.

M. Wolf, S. Messinger, S. Furth, 2016, Clinical journal of the American Society of Nephrology : CJASN.

The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Secondary and Tertiary Renal Hyperparathyroidism

J. Olson, M. Wolf, F. Nwariaku, 2022, Annals of surgery.

Vitamin D Metabolic Ratio and Risks of Death and CKD Progression

A. Go, Mahboob Rahman, B. Kestenbaum, 2019, Kidney international reports.

Fibroblast growth factor23 is associated with axonal integrity and neural network architecture in the human frontal lobes

M. Wolf, R. Adams, L. Bonilha, 2018, PloS one.

Design and Rationale of HiLo: A Pragmatic, Randomized Trial of Phosphate Management for Patients Receiving Maintenance Hemodialysis

M. Wolf, H. Chakraborty, S. Beddhu, 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Increasing use of vitamin D supplementation in the chronic renal insufficiency cohort study.

M. Wolf, J. Shults, H. Feldman, 2014, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Hypophosphatemia after intravenous iron therapy: Comprehensive review of clinical findings and recommendations for management.

H. Tilg, M. Wolf, H. Zoller, 2021, Bone.

Associations of Socioeconomic Status and Processed Food Intake with Serum Phosphorus in Community-Living Adults : the Multi-Ethnic Study of Atherosclerosis ( MESA )

B. Kestenbaum, M. Wolf, A. Roux, 2015 .

Pivoting From PTH to FGF23 to Mend Breaking Hearts on Dialysis.

M. Wolf, S. Murray, M. Wolf, 2021, Circulation research.

The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemia

M. Wolf, G. Chertow, G. Block, 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Second Chances to Improve ESRD Outcomes With a Second-Generation Calcimimetic.

M. Wolf, J. Middleton, M. Wolf, 2017, JAMA.

Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study

M. Wolf, D. Goldsmith, S. Marx, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Cord Blood Ferritin and Fibroblast Growth Factor-23 Levels in Neonates.

A. Mendez, K. Mestan, J. Josefson, 2016, Journal of Clinical Endocrinology and Metabolism.

FGF23 (Fibroblast Growth Factor-23) and Incident Hypertension in Young and Middle-Aged Adults: The CARDIA Study

Lihui Zhao, C. Yancy, M. Wolf, 2018, Hypertension.

Effects of ferric carboxymaltose on markers of mineral and bone metabolism: a single-center prospective observational study of women with iron deficiency.

M. Wolf, Xuan Cai, Jungwha Lee, 2020, Bone.

Effects of dietary phosphate restriction and phosphate binders on FGF23 levels in CKD.

Huiliang Xie, M. Wolf, A. Mendez, 2013, Clinical journal of the American Society of Nephrology : CJASN.

A physiologic-based approach to the evaluation of a patient with hyperphosphatemia.

D. Leaf, M. Wolf, M. Wolf, 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease.

M. Wolf, H. Jüppner, O. Gutiérrez, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Fibroblast Growth Factor 23 and Exercise Capacity in Heart Failure with Preserved Ejection Fraction.

Sanjiv J. Shah, Ravi B. Patel, M. Wolf, 2020, Journal of cardiac failure.

DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney disease

M. Wolf, Jian Q. Feng, S. White, 2019, Bone Research.

Genetic background influences cardiac phenotype in murine chronic kidney disease

Claire Gerber, Aline Martin, Myles Wolf, 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Fibroblast growth factor 23 and Inflammation in CKD.

Huiliang Xie, M. Wolf, M. Kretzler, 2012, American Society of Nephrology. Clinical Journal.

Iron status, fibroblast growth factor 23 and cardiovascular and kidney outcomes in chronic kidney disease.

A. Go, Mahboob Rahman, M. Wolf, 2021, Kidney international.

Safety and efficacy of iron isomaltoside 1000/ferric derisomaltose versus iron sucrose in patients with chronic kidney disease: the FERWON-NEPHRO randomized, open-label, comparative trial

M. Wolf, P. Kalra, S. Bhandari, 2020, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Insulin Resistance But Not Inflammation Is Associated With Gestational Hypertension

M. Wolf, R. Thadhani, J. Ecker, 2002, Hypertension.

First trimester insulin resistance and subsequent preeclampsia: a prospective study.

M. Wolf, R. Thadhani, J. Ecker, 2002, The Journal of clinical endocrinology and metabolism.

Title Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients : a cross-sectional study in the chronic renal insufficiency cohort ( CRIC ) Permalink

A. Go, M. Wolf, M. Keane, 2013 .

Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.

Anna C. Porter, I. D. de Boer, M. Wolf, 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Prognostic value of bone‐ and vascular‐derived molecular biomarkers in hemodialysis and renal transplant patients: a systematic review and meta‐analysis

M. Wolf, J. Redón, R. Oberbauer, 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Circulating levels of the antiangiogenic marker sFLT-1 are increased in first versus second pregnancies.

Robert N. Taylor, M. Wolf, F. Epstein, 2005, American journal of obstetrics and gynecology.

Racial Differences in the Associations Between Food Insecurity and Fibroblast Growth Factor 23 in the Coronary Artery Risk Development in Young Adults Study.

M. Wolf, M. Carnethon, P. Gordon-Larsen, 2020, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Associations of socioeconomic status and processed food intake with serum phosphorus concentration in community-living adults: the Multi-Ethnic Study of Atherosclerosis (MESA).

A. D. Diez Roux, B. Kestenbaum, I. D. de Boer, 2012, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Impact of poverty on serum phosphate concentrations in the Third National Health and Nutrition Examination Survey.

M. Wolf, O. Gutiérrez, T. Isakova, 2011, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Sleep disordered breathing and fibroblast growth factor 23 in the Hispanic Community Health Study/Study of Latinos.

S. Redline, D. Zeng, M. Wolf, 2018, Bone.

Serial Fibroblast Growth Factor 23 Measurements and Risk of Requirement for Kidney Replacement Therapy: The CRIC (Chronic Renal Insufficiency Cohort) Study.

I. D. de Boer, M. Wolf, H. Feldman, 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Original Investigation Associations of FGF23 with 10-Year Change in eGFR and UACR and with Incident CKD in the CARDIA Cohort

C. Yancy, M. Carnethon, O. Gutiérrez, 2023 .

Chapters and Other Papers 1-6-2018 FGF 23 and Left Ventricular Hypertrophy in Children with CKD .

M. Wolf, A. Betoko, S. Furth, 2019 .

Predictors of Net Acid Excretion in the Chronic Renal Insufficiency Cohort (CRIC) Study.

Mahboob Rahman, M. Wolf, J. Pendergast, 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Acid Load and Phosphorus Homeostasis in CKD.

Mahboob Rahman, M. Wolf, H. Feldman, 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

FGF23 or PTH: which comes first in CKD ?

M. Wolf, T. Isakova, M. Wolf, 2010, Kidney international.

Second chances in mineral metabolism.

M. Wolf, M. Wolf, 2010, Clinical journal of the American Society of Nephrology : CJASN.

A Prospective Cohort Study of Mineral Metabolism After Kidney Transplantation

M. Wolf, M. Weir, R. Mannon, 2015, Transplantation.

(1-34) Parathyroid hormone infusion acutely lowers fibroblast growth factor 23 concentrations in adult volunteers.

M. Wolf, O. Gutiérrez, T. Isakova, 2012, Clinical journal of the American Society of Nephrology : CJASN.

Importance of Extra-Renal CYP24A1 Expression for Maintaining Mineral Homeostasis

M. Wolf, A. Grabner, Melody Shi, 2021, Journal of the Endocrine Society.

Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome

M. Wolf, W. Strauss, J. Glaspy, 2021, Advances in Therapy.

Nephropathic Cystinosis: A Distinct Form of CKD-Mineral and Bone Disorder that Provides Novel Insights into the Regulation of FGF23.

M. Wolf, W. Gahl, C. Ferreira, 2020, Journal of the American Society of Nephrology : JASN.

Fibroblast Growth Factor-23 Fans the Flames of Heart and Kidney Failure.

M. Wolf, Rupal Mehta, M. Wolf, 2015, JACC. Heart failure.

Daily variability in mineral metabolites in CKD and effects of dietary calcium and calcitriol.

Huiliang Xie, M. Wolf, H. Jüppner, 2012, Clinical journal of the American Society of Nephrology : CJASN.

Drug Development in Kidney Disease: Proceedings From a Multistakeholder Conference.

M. Wolf, N. Tangri, T. Greene, 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Vitamin D and Health Outcomes: Then Came the Randomized Clinical Trials.

M. Wolf, Anika Lucas, M. Wolf, 2019, Journal of the American Medical Association (JAMA).

Health Outcomes With Vitamin D Supplementation-Reply.

M. Wolf, Anika Lucas, M. Wolf, 2020, JAMA.

Typographical Error.

M. Wolf, Anika Lucas, M. Wolf, 2020, JAMA.

Data Error in Viewpoint on COVID-19 in Italy.

M. Wolf, Anika Lucas, M. Wolf, 2020, JAMA.

Longitudinal FGF23 Trajectories and Mortality in Patients with CKD.

M. Pencina, I. D. de Boer, M. Wolf, 2017, Journal of the American Society of Nephrology : JASN.

Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD.

M. Wolf, Hang Lee, O. Gutiérrez, 2008, Journal of the American Society of Nephrology.

Renal proximal tubule cells: power and finesse

M. Wolf, Michael Fuchs, M. Wolf, 2023, The Journal of clinical investigation.

Pulmonary Hypertension Subtypes and Mortality in CKD.

M. Wolf, L. Shaw, S. Rajagopal, 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Oral Ferric Citrate Hydrate Associated With Less Oxidative Stress Than Intravenous Saccharated Ferric Oxide

M. Wolf, H. Hirakata, T. Akiba, 2017, Kidney international reports.

Association of circulating cardiac biomarkers with electrocardiographic abnormalities in chronic kidney disease.

A. Go, M. Wolf, E. Soliman, 2020, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Vitamin D in patients with renal failure: A summary of observational mortality studies and steps moving forward

M. Wolf, R. Thadhani, M. Wolf, 2007, The Journal of Steroid Biochemistry and Molecular Biology.

Vitamin D in patients with kidney disease: cautiously optimistic.

M. Wolf, R. Thadhani, M. Wolf, 2007, Advances in chronic kidney disease.

Vitamin D levels and early mortality among incident hemodialysis patients.

M. Wolf, M. Tonelli, C. Camargo, 2007, Kidney international.

FGF23: fashion or physiology?

M. Wolf, M. Wolf, 2010, Clinical journal of the American Society of Nephrology : CJASN.

Fibroblast Growth Factor 23 and Anemia in the Chronic Renal Insufficiency Cohort Study.

A. Go, M. Wolf, H. Feldman, 2017, Clinical journal of the American Society of Nephrology : CJASN.

Differential Effects of Vitamin D Receptor Agonists on Gene Expression in Neonatal Rat Cardiomyocytes

M. Wolf, M. Nakane, Yung-wu Chen, 2011, Cardiovascular Drugs and Therapy.

Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE Trial.

A. Cheung, M. Wolf, L. Fried, 2019, Journal of the American Society of Nephrology : JASN.

Fibroblast Growth Factor-23, Heart Failure Risk, and Renin–Angiotensin–Aldosterone-System Blockade in Hypertension: The MESA Study

C. Yancy, M. Szklo, B. Kestenbaum, 2018, American journal of hypertension.

Coupling FGF 23 Production and Cleavage : Iron Deficiency , Rickets and Kidney Disease

M. Wolf, K. White, M. Wolf, 2015 .

Effects of Vitamin D2 Supplementation on Vitamin D3 Metabolism in Health and CKD.

B. Kestenbaum, C. Robinson-Cohen, I. D. de Boer, 2017, Clinical journal of the American Society of Nephrology : CJASN.

34 PREECLAMPSIA AND FUTURE CARDIOVASCULAR DISEASE: POTENTIAL ROLE OF ALTERED ANGIOGENESIS AND INSULIN RESISTANCE.

R. Thadhani, C. Hubel, M. Wolf, 2004, Journal of Investigative Medicine.

Risk Prediction Models for Atherosclerotic Cardiovascular Disease in Patients with Chronic Kidney Disease: The CRIC Study

Byron C. Jaeger, Mahboob Rahman, M. Wolf, 2022, Journal of the American Society of Nephrology : JASN.

GFR-Specific versus GFR-Agnostic Cutoffs for Parathyroid Hormone and Fibroblast Growth Factor-23 in Advanced Chronic Kidney Disease

M. Wolf, O. Djurdjev, A. Levin, 2019, American Journal of Nephrology.

Creatinine versus cystatin C for renal function-based mortality prediction in an elderly cohort: The Northern Manhattan Study

R. Sacco, M. Wolf, M. Elkind, 2020, PloS one.

Creatinine- versus cystatin C-based renal function assessment in the Northern Manhattan Study

R. Sacco, M. Wolf, M. Elkind, 2018, PloS one.

Persistent High Serum Bicarbonate and the Risk of Heart Failure in Patients With Chronic Kidney Disease (CKD): A Report From the Chronic Renal Insufficiency Cohort (CRIC) Study

Mahboob Rahman, T. Hostetter, M. Wolf, 2015, Journal of the American Heart Association.

Diagnosis and Management of Mineral Metabolism in CKD

M. Wolf, A. Dubey, I. Bhan, 2010, Journal of general internal medicine.

Plasma Serotonin and Cardiovascular Outcomes in Chronic Kidney Disease

M. Wolf, T. Isakova, Daniel L. Edmonston, 2023, Journal of the American Heart Association.

Does a rise in plasma erythropoietin after high-altitude exposure affect FGF23 in healthy volunteers on a normal or low-phosphorus diet?

M. Wolf, D. Fliser, S. Wagenpfeil, 2019, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Randomized evaluation of efficacy and safety of ferric carboxymaltose in patients with iron deficiency anaemia and impaired renal function (REPAIR-IDA): rationale and study design.

M. Wolf, L. Szczech, R. Harrington, 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Clinical Research Career Development: The Individual Perspective

M. Wolf, M. Wolf, 2002, Academic medicine : journal of the Association of American Medical Colleges.

Magnesium and Fracture Risk in the General Population and Patients Receiving Dialysis: A Narrative Review

A. Garg, M. Wolf, M. Tonelli, 2023, Canadian journal of kidney health and disease.

Randomised clinical trial of ferric citrate hydrate on anaemia management in haemodialysis patients with hyperphosphataemia: ASTRIO study

M. Wolf, H. Hirakata, T. Akiba, 2019, Scientific Reports.

Phosphate REINs in the renoprotective benefit of ACE inhibition.

M. Wolf, G. Block, M. Wolf, 2011, Journal of the American Society of Nephrology : JASN.

Should activated vitamin D be used in patients with end‐stage renal disease and low levels of parathyroid hormone?

M. Wolf, M. Wolf, 2011, Seminars in dialysis.

Active vitamin D and survival.

M. Wolf, M. Wolf, 2008, Journal of the American Society of Nephrology : JASN.

Associations of dietary phosphorus intake, urinary phosphate excretion, and fibroblast growth factor 23 with vascular stiffness in chronic kidney disease.

O. Gutiérrez, T. Isakova, Kelsey Smith, 2013, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Precise regulation of FGF 23 is required for bone health

M. Wolf, V. David, M. Wolf, 2016 .

High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) Study.

A. Go, M. Wolf, N. Bansal, 2015, Journal of the American Society of Nephrology : JASN.

Hypophosphataemia following ferric derisomaltose and ferric carboxymaltose in patients with iron deficiency anaemia due to inflammatory bowel disease (PHOSPHARE-IBD): a randomised clinical trial

M. Wolf, W. Reinisch, I. Blumenstein, 2022, Gut.

Risk Factors for and Effects of Persistent and Severe Hypophosphatemia Following Ferric Carboxymaltose

M. Wolf, H. Zoller, B. Schaefer, 2021, The Journal of clinical endocrinology and metabolism.

Persistent Hypophosphatemia after Ferric Carboxymaltose Is Associated with Persistent Changes in Biomarkers of Bone Metabolism

H. Zoller, B. Schaefer, M. Wolf, 2020 .

Safety of ferric derisomaltose and iron sucrose in patients with iron deficiency anemia: The FERWON‐IDA/NEPHRO trials

M. Wolf, P. Kalra, S. Bhandari, 2020, American journal of hematology.

Dietary factors and fibroblast growth factor-23 levels in young adults with African ancestry

A. Luke, T. Forrester, C. Sempos, 2017, Journal of Bone and Mineral Metabolism.

Association of Serum Phosphorus Level With Anemia in Kidney Transplant Recipients

M. Wolf, C. Kovesdy, M. Molnar, 2011, Transplantation.

Use of Measures of Inflammation and Kidney Function for Prediction of Atherosclerotic Vascular Disease Events and Death in Patients With CKD: Findings From the CRIC Study.

M. Budoff, A. Go, Mahboob Rahman, 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.